Skip to Content

755 (Temozolomide 180 mg)

Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 755

Temozolomide

Imprint:
755
Strength:
180 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals (USA) Inc.
Manufacturer:
Cadila Healthcare Limited
National Drug Code (NDC):
68382-0755

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide